The influence of antiretroviral therapy on the QTc interval in an African cohort

Clinical Infectious Diseases

Volumn 54, Issue 3, 2012, Pages 448-449

  Shavadia, J ^a   Shah, R ^a   Yonga, G ^a   Patel, R ^b   Stebbing, J ^b   Nelson, M ^b  

^a AGA KHAN UNIVERSITY   (Kenya)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;

ADULT; AFRICA; ANTIVIRAL THERAPY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; MALE; PERICARDITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QT PROLONGATION; TORSADE DES POINTES;

ANTI-HIV AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HIV INFECTIONS; HUMANS; KENYA; LONG QT SYNDROME; MALE;

EID: 84855878393     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir712     Document Type: Letter

References (10)

1. Ntsekhe M, Mayosi BM. Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med 2009;6:120-7.
2. Magula NP, Mayosi BM. Cardiac involvement in HIV-infected people living in Africa: a review. Cardiovasc J S Afr 2003;14:231-7. (Pubitemid 37462995)
3. Singh M, Arora R, Jawad E. HIV protease inhibitors induced prolongation of the QT interval: electrophysiology and clinical implications. Am J Ther 2010;17:e193-201.
4. Sani MU, Okeahialam BN. QTc interval prolongation in patients with HIV and AIDS. J Natl Med Assoc 2005;97:1657-61. (Pubitemid 41753112)
5. Okeahialam BN, Sani MU. Heart disease in HIV/AIDS: how much is due to cachexia? Afr J Med Sci 2006;35(Suppl): 99-102.
6. Qaqa AY, Shaaban H, DeBari VA, et al. Viral load and CD4+ cell count as risk factors for prolonged QT interval in HIV-infected subjects: a cohort-nested casecontrol study in an outpatient population. Cardiology 2010;117:105-11.
7. Anson BD, Weaver JG, Ackerman MJ, et al. Blockade of HERG channels by HIV protease inhibitors. Lancet 2005;365:682-6. (Pubitemid 40260891)
8. Chinello P, Lisena FP, Angeletti C, Boumis E, Papetti F, Petrosillo N. Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients. J Infect 2007;54:597-602. (Pubitemid 46731224)
9. Damle B, Fosser C, Ito K, et al. Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study. J Clin Pharmacol 2009;49:291-300.
10. Soliman EZ, Lundgren JD, Roediger MP, et al. Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations. AIDS 2011;25:367-77.